Matches in SemOpenAlex for { <https://semopenalex.org/work/W289239286> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W289239286 endingPage "30" @default.
- W289239286 startingPage "425" @default.
- W289239286 abstract "Reports have shown that anticardiolipin (aCL) antibodies present in patients with autoimmune diseases are dependent on the cofactor,beta2 glycoprotein I (beta2 GPI), as opposed to aCL antibodies seen in infectious diseases such as syphilis, HIV hepatitis C, etc. The assay for anti-beta2GPI antibodies has been reported to be more specific for antiphospholipid syndrome (APS). However, the prevalence of these antibodies in diseases such as leishmaniasis and leptospirosis remains unknown. The aim of the present study was determine the prevalence of antibodies to cardiolipin and to beta2GPI in patients with different infectious diseases, including leptospirosis, syphilis and leishmaniasis.Samples from patients with Kala-azar (visceral leishmaniasis), syphilis or leptospirosis were tested for IgG and IgM anticardiolipin and IgG anti-beta2GPI antibodies by ELISA.In patients with Kala-azar the prevalence of IgG aCL, IgM aCL and anti-beta2GPI was 6% (2/30), 3% (1/30) and 53% (16/30), respectively. In syphilis the prevalence was 18% (14/74), 13% (10/74) and 10% (8/70), respectively. In leptospirosis the frequency of these antibodies was 23% (9/39), 10% (4/39) and 17% (6/34), respectively. There was no statistical correlation between aCL and anti-beta2GPI antibodies in these diseases.This study clearly shows a significant prevalence of anti-beta2GPI antibodies in leptospirosis and leishmaniasis and syphilis. This indicates that the assay for antibeta2GPI antibodies should be thoroughly validated before it is introduced as a definitive tool for the diagnosis of APS, testing a larger number of sera from patients with a wider range of clinical conditions." @default.
- W289239286 created "2016-06-24" @default.
- W289239286 creator A5001909193 @default.
- W289239286 creator A5007750474 @default.
- W289239286 creator A5016159916 @default.
- W289239286 creator A5023350758 @default.
- W289239286 creator A5039414460 @default.
- W289239286 creator A5040395107 @default.
- W289239286 creator A5072160809 @default.
- W289239286 creator A5088294666 @default.
- W289239286 creator A5090693449 @default.
- W289239286 date "2001-08-09" @default.
- W289239286 modified "2023-09-30" @default.
- W289239286 title "Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar." @default.
- W289239286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11491498" @default.
- W289239286 hasPublicationYear "2001" @default.
- W289239286 type Work @default.
- W289239286 sameAs 289239286 @default.
- W289239286 citedByCount "20" @default.
- W289239286 countsByYear W2892392862012 @default.
- W289239286 countsByYear W2892392862013 @default.
- W289239286 countsByYear W2892392862018 @default.
- W289239286 countsByYear W2892392862020 @default.
- W289239286 crossrefType "journal-article" @default.
- W289239286 hasAuthorship W289239286A5001909193 @default.
- W289239286 hasAuthorship W289239286A5007750474 @default.
- W289239286 hasAuthorship W289239286A5016159916 @default.
- W289239286 hasAuthorship W289239286A5023350758 @default.
- W289239286 hasAuthorship W289239286A5039414460 @default.
- W289239286 hasAuthorship W289239286A5040395107 @default.
- W289239286 hasAuthorship W289239286A5072160809 @default.
- W289239286 hasAuthorship W289239286A5088294666 @default.
- W289239286 hasAuthorship W289239286A5090693449 @default.
- W289239286 hasConcept C159047783 @default.
- W289239286 hasConcept C159654299 @default.
- W289239286 hasConcept C203014093 @default.
- W289239286 hasConcept C2776555147 @default.
- W289239286 hasConcept C2776983459 @default.
- W289239286 hasConcept C2778033228 @default.
- W289239286 hasConcept C2778689377 @default.
- W289239286 hasConcept C2780542935 @default.
- W289239286 hasConcept C2781429187 @default.
- W289239286 hasConcept C3013748606 @default.
- W289239286 hasConcept C71924100 @default.
- W289239286 hasConceptScore W289239286C159047783 @default.
- W289239286 hasConceptScore W289239286C159654299 @default.
- W289239286 hasConceptScore W289239286C203014093 @default.
- W289239286 hasConceptScore W289239286C2776555147 @default.
- W289239286 hasConceptScore W289239286C2776983459 @default.
- W289239286 hasConceptScore W289239286C2778033228 @default.
- W289239286 hasConceptScore W289239286C2778689377 @default.
- W289239286 hasConceptScore W289239286C2780542935 @default.
- W289239286 hasConceptScore W289239286C2781429187 @default.
- W289239286 hasConceptScore W289239286C3013748606 @default.
- W289239286 hasConceptScore W289239286C71924100 @default.
- W289239286 hasIssue "4" @default.
- W289239286 hasLocation W2892392861 @default.
- W289239286 hasOpenAccess W289239286 @default.
- W289239286 hasPrimaryLocation W2892392861 @default.
- W289239286 hasRelatedWork W1675567986 @default.
- W289239286 hasRelatedWork W178524133 @default.
- W289239286 hasRelatedWork W2074891942 @default.
- W289239286 hasRelatedWork W2115030683 @default.
- W289239286 hasRelatedWork W2276002667 @default.
- W289239286 hasRelatedWork W2410773192 @default.
- W289239286 hasRelatedWork W2465725254 @default.
- W289239286 hasRelatedWork W259875926 @default.
- W289239286 hasRelatedWork W289239286 @default.
- W289239286 hasRelatedWork W4225288573 @default.
- W289239286 hasVolume "19" @default.
- W289239286 isParatext "false" @default.
- W289239286 isRetracted "false" @default.
- W289239286 magId "289239286" @default.
- W289239286 workType "article" @default.